Phibro Animal Health | PAHC - Zysk Brutto





Zysk Brutto Zmiana Data
Align Technology USD 176.6M 81.86M 2025-12
ANI Pharmaceuticals USD 49.52M 39M 2025-09
Assertio Holdings USD -2.88M 648K 2024-09
Aurora Cannabis CAD -1.58M 48.55M 2025-12
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Canopy Growth CAD -62.26M 60.84M 2025-12
Corcept Therapeutics USD 15.24M 16.45M 2025-09
Eli Lilly USD 7.23B 456M 2025-09
Henry Schein USD 137M 16M 2025-09
Idexx Laboratories USD 306.98M 37.79M 2025-12
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Merck USD 6.74B 22M 2025-09
Nektar Therapeutics USD -37.05M 15.27M 2024-09
Pacira USD 9.52M 11.45M 2025-09
Phibro Animal Health USD 38.62M 1.26M 2025-12
Prestige Brands USD 69.13M 7.35M 2025-09
Supernus Pharmaceuticals USD -1.91M 56.04M 2025-12
Zoetis USD 887M 15M 2025-09